Model Number 37612 |
Device Problems
Delayed Charge Time (2586); Charging Problem (2892); Communication or Transmission Problem (2896)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 04/25/2013 |
Event Type
malfunction
|
Manufacturer Narrative
|
Dystonia is not an approved indication for the activa rc (model 37612); therefore, this is an off-label use of this device.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a consumer regarding a patient with an implantable neurostimulator (ins) for dystonia and movement disorders.It was reported that the patient's ins had 1/2 charge, and after 2.5 hours of charging with full coupling, the recharger did not indicate charge sufficient or full screen.When they checked the ins with the patient programmer, the ins indicated full charge.The caller was told that the ins charge should only take 10 minutes but the patient's ins has taken 45 minutes to an hour to charge the last 1/4.The caller indicated charging times have been consistent since implant.No patient symptoms were reported.No further complications were reported or anticipated with the event.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the consumer reported the cause of the recharging taking longer than expected was the patient living in a long-term care facility with it being difficult for the staff to get training on how to charge the battery.According to the consumer the ¿battery could be difficult to charge since the patient could lose bars if they moved.¿ to resolve the recharging taking longer than expected the consumer told the staff to monitor the charging closer.No patient symptoms or further complications were anticipated.
|
|
Manufacturer Narrative
|
D2: please note that this device was used in an off-label manner as it was implanted for dystonia.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|